Targeted nanoparticle-based drug delivery and diagnosis

Journal of Drug Targeting

Volumn 15, Issue 3, 2007, Pages 163-183

  Emerich, Dwaine F ^a   Thanos, Christopher G ^a  

^a LCT BioPharma Inc   (United States)

Author keywords

Drug delivery; Molecular diagnostics; Nanomedicine; Nanoparticle; Nanotechnology; Targeted delivery

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; CISPLATIN; DENDRIMER; DIAGNOSTIC AGENT; DOXORUBICIN; EMULSIFYING AGENT; FOLIC ACID; GLYCOSAMINOGLYCAN; IBUPROFEN; IODINE 125; LIPOSOME; MACROGOL; MELPHALAN; METOPROLOL; NANOCARRIER; NANOCOATING; NANOPARTICLE; NANOTUBE; NAPROXEN; NK 105; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PACLITAXEL; PLASMID DNA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SOLID LIPID NANOPARTICLE; TESTOSTERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; BREAST CANCER; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG RELEASE; DRUG TARGETING; GASTROINTESTINAL DISEASE; GENE DELIVERY SYSTEM; HUMAN; HYDROGEL; LIVER TOXICITY; MALIGNANT NEOPLASTIC DISEASE; MAXIMUM PLASMA CONCENTRATION; MICELLE; NANOENCAPSULATION; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SOLID TUMOR;

DRUG CARRIERS; MOLECULAR DIAGNOSTIC TECHNIQUES; NANOMEDICINE; NANOPARTICLES;

EID: 34147176584     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701231810     Document Type: Review

References (203)

1. Akerman, ME, Chan, WC, Laakkonen, P., Bhatia, SN and Ruoslahti, E. (2002) Nanocrystal targeting in vivo. Proc Natl Acad Sci USA, 99, pp. 12617-12621.
2. Allen, TM (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer, 2, pp. 750-763.
3. Allen, TM and Cullis, PR (2004) Drug delivery systems: Entering the mainstream. Science, 303, pp. 1818-1822.
4. Alpar, HO, Field, WN, Hayes, K. and Lewis, DA (1990) The transport of microspheres from the gastrointestinal tract to infammatory air pouches in the rat. J Pharm Pharmacol, 41, pp. 194-196.
5. Alyautdin, RN, Petrov, VE, Langer, K., Berthold, A., Kharkevich, DA and Kreuter, J. (1997) Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm Res, 14, pp. 325-328.
6. Alyautdin, RN, Tezikov, EB, Ramge, P., Kharkevich, DA, Begley, DJ and Kreuter, J. (1998) Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: An in situ brain perfusion study. J Microencapsul, 15, pp. 67-74.
7. Anderson, SA, Rader, RK, Westlin, WF, Null, C., Kackson, D., Lanza, GM, Wickline, SA and Kotyk, JJ (2000) Magnetic resonance contrast enhancement of neovascular with v3-targeted nanoparticles. Magn Reson Med, 44, pp. 433-439.
8. 2 activation of liposome-forming prodrugs. J Med Chem, 47, pp. 1694-1703.
9. Antohe, F., Heltianu, C. and Simionescu, M. (1991) Albumin-binding proteins of endothelial cells: Immunocytochemical detection of the 18 kDa peptide. Eur J Cell Biol, 56, pp. 34-42.
10. Antohe, F., Dobrila, L., Heltianu, C., Simionescu, N. and Simionescu, M. (1993) Albumin-binding proteins function in the receptor-mediated binding and transcytosis of albumin across cultured endothelial cells. Eur J Cell Biol, 60, pp. 268-275.
11. Arap, W., Pasqualini, R. and Ruoslahti, E. (1998) Cancer treatment by targeted drug delivery to tumour vasculature in a mouse model. Science, 279, pp. 377-338.
12. Assa-Munt, N., Jia, X., Laakkonen, P. and Ruoslahti, E. (2001) Solution structures and integrin binding activities of an RGD peptide with two isomers. Biochemistry, 40, pp. 2373-2378.
13. Ballou, B., Lagerholm, BC, Ernst, LA, Bruchez, MP and Waggoner, AS (2004) Noninvasive imaging of quantum dots in mice. Bioconjug Chem, 15, pp. 79-86.
14. Barathur, R., Bookout, J., Sreevatsan, S., Gordon, J., Werner, M., Thor, G. and Worthington, M. (2002) New disc-based technologies for diagnostic and research applications. Psychiatr Genet, 12, pp. 193-206.
15. Barenholz, Y. (2001) Liposome application: Problems and prospects. Curr Opin Coll Interface Sci, 6, pp. 66-77.
16. Bargoni, A., Cavalli, R., Zara, GP, Fundaro, A., Caputo, O. and Gasco, MR (2001) Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II-tissue distribution. Pharm Res, 43, pp. 497-502.
17. Berton, M., Turelli, P., Trono, D., Stein, CA, Allemann, E. and Gurny, R. (2001) Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles. Pharm Res, 18, pp. 1096-1101.
18. Bos, GW, Kanellos, T., Crommelin, DJ, Hennink, WE and Howard, CR (2004) Cationic polymers that enhance the performance of HbsAg DNA in vivo. Vaccine, 23, pp. 460-469.
19. Bosi, S., Ros, T Da, Castellano, S., Banfi, E. and Prato, M. (2000) Antimycobacterial activity of ionic fullerene derivatives. Bioorg Med Chem Lett, 10, pp. 1043-1045.
20. Bruchez, M., Moronne, M., Gin, P., Weiss, S. and Alivisatos, AP (1998) Semiconductor nanocrystals as fluorescent biological labels. Science, 281, pp. 2013-2016.
21. Brusewitz, C., Schendler, A., Funke, A., Wagner, T. and Lipp, R. (2007) Novel poloxamer-based nanoemulsions to enhance the interstinal absorption of active compounds. Int J Pharm, 329, pp. 173-181.
22. Bustami, R., Chan, H., Dehghani, F. and Foster, NR (2000) Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide. Pharm Res, 17, pp. 1360-1366.
23. Cao, YC, Jin, R. and Mirkin, CA (2002) Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection. Science, 297, pp. 1536-1540.
24. Cao, YC, Jin, R., Nam, JM, Thaxton, CS and Mirkin, CA (2003) Raman dye-labeled nanoparticle probes for proteins. J Am Chem Soc, 125, pp. 4676-1467.
25. Carr, KE, Hazzard, RA, Reid, S. and Hodges, GM (1996) The effect of size on uptake of orally administered latex microparticles in the small intestine and transport to mesenteric lymph nodes. Pharm Res, 13, pp. 1205-1209.
26. Chan, WC, Maxwell, DJ, Gao, X., Bailey, RE, Han, M. and Nie, S. (2002) Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol, 13, pp. 40-46.
27. Chapat, S., Frey, V., Claperon, N., Bouchaud, C., Puisieux, F., Couvreur, P., Rossignol, P. and Delattre, J. (1991) Efficiency of liposomal ATP in cerebral ischemia: Bioavailability features. Brain Res Bull, 26, pp. 339-342.
28. Chen, R., Zhang, Y., Wang, D. and Dai, H. (2001) Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. J Am Chem Soc, 123, pp. 3838-3839.
29. Chen, S., Webster, S., Czerw, R. and Carroll, DL (2004) Morphology effects on the optical properties of silver nanoparticles. J Nanosci Nanotechnol, 4, pp. 254-259.
30. Cherukuri, P., Bachilo, SM, Litovsky, SH and Weisman, RB (2004) Near-infrared fluorescence microscopy of single-walled carbon nanotunes in phagocytic cells. J Am Chem Soc, 126, pp. 15638-15639.
31. Chickering, DE, Harris, WP and Mathiowitz, E. (1995) A micro-tensiometer for the analysis of bioadhesive microspheres. Biomed Instrum Technol, 29:501, p. 512.
32. Chickering, DE, Jacob, JS, Desai, T., Harrison, M., Harris, WP, Morrell, CN and Mathiowitz, E. (1997) Bioadhesive microspheres: III. An in vivo transit and bioavailability study of alginate and poly(Fumaric-co-Sebacic Anhydride). J Control Release, 48, pp. 35-46.
33. Christofidou-Solomidou, M., Pietra, GG, Solomides, CC, Arguiris, E., Harshaw, D., Fitzgerald, GA, Albelda, SM and Muzykantov, VR (2000) Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol, 278, pp. 794-805.
34. Clark, H., Kopelman, R., Tjalkens, R. and Philbert, MA (1999) Optical nanosensors for chemical analysis inside single living cells. 2. Sensors for pH and calcium and the intracellular application of PEBBLE sensors. Anal Chem, 71, pp. 4837-4843.
35. Cohen, S. and Bernstein, H. (1996) Microparticulate systems for the delivery of proteins and vaccines, Marcel Dekker, New York, NY
36. Cohen-Sacks, H., Najajreh, Y., Tchaikovski, V., Gao, G., Elazer, V., Dahan, R., Gati, I., Kanaan, M., Waltenberger, J. and Golomb, G. (2002) Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis. Gene Ther, 9, pp. 1607-1616.
37. Csaki, A., Moller, R. and Fritzsche, W. (2002) Gold nanoparticles as novel label for DNA diagnostics. Expert Rev Mol Diagn, 2, pp. 187-193.
38. Curnis, F., Sacchi, A. and Corti, A. (2002) Improving chemotherapeutic drug penetration in tumours by vascular targeting and barrier alteration. J Clin Invest, 110, pp. 475-482.
39. Damge, C., Aprahamian, M., Marchais, H., Benoit, JP and Pinget, M. (1996) Intestinal absorption of PLAGA microspheres in the rat. J Anat, 189, pp. 491-501.
40. Davidson, J., Mouritsen, OG and Jørgensen, K. (2002) Synergistic permeability enhancing effect of lysophospholipids and fatty acids on lipid membranes. Biochim Biophys Acta, 1564, pp. 256-262.
41. 2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue. Biochim Biophys Acta, 1609, pp. 95-101.
42. D'Emanuele, A., Jevprasephant, R., Penny, J. and Attwood, D. (2004) The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. J Control Release, 95, pp. 447-453.
43. Dempski, R., Scholtz, E., Oberholtzer, E. and Yeh, K. (1989) Pharmaceutical design and development of a sinemet controlled-release formulation. Neurology, 39, pp. 20-24.
44. Drummond, DC, Meyer, O., Hong, K., Kirpotin, DB and Papahajopoulos, D. (1991) Optimizing liposomes for delivery of chemotherapeutic agents to solid tumours. Pharm Rev, 51, pp. 691-743.
45. Duchêne, D., Touchard, F. and Peppas, NA (1988) Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm, 14, pp. 283-318.
46. Dugan, LL, Lovette, E. and Cuddihy, S. (2000) Carboxyfullerenes as neuroprotective antioxidants. Fullerenes: Chemistry, physics, and technology, John Wiley and Sons, New York, NY
47. Dunning, MD, Lakatos, A., Loizou, L., Kettunen, M., French-Constant, C., Brindle, KM and Franklin, RJ (2004) Superparamagnetic iron oxide-labeled Schwaan cells and olfactory ensheathing cells can be traced in vivo by magnetic resonance imaging and retain their functional properties after transplantation into the CNS. J Neurosci, 24, pp. 9799-9810.
48. Ebel, JP (1990) A method for quantifying particle absorption from the small intestine of mouse. Pharm Res, 7, pp. 848-851.
49. Eliceiri, P. and Cheresh, DA (1999) The role of alpha v integrins during angiogenesis: Insights into potential mechanisms of action and clinical development. J Clin Invest, 103, pp. 1227-1230.
50. Emerich, DF and Thanos, C. (2003) Nanotechnology and medicine: The here and now and future prospects. Expert Opin Biol Ther, 3, pp. 655-663.
51. Ermak, TH, Dougherty, EP, Bhagat, HR, Kabok, Z. and Pappo, J. (1995) Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's Patch M cells. Cell Tissue Res, 279, pp. 433-436.
52. Fabel, K., Dietrich, J., Hau, P., Wismeth, C., Winner, B., Przywara, S., Steinbrecher, A., Ullrich, W. and Bogdahn, U. (2001) Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer, 92, pp. 1936-1942.
53. Feynman, R. (1959) Engineering and science
54. Flacke, S., Fischer, S., Scott, MJ, Fuhrhop, RJ, Allen, JS, McLean, M., Winter, P., Sicard, GA, Gaffney, PJ, Wickline, SA and Lanza, GM (2001) Novel MRI contrast agent for molecular imaging of fibrin implications for detecting vulnerable plaques. Circulation, 104, pp. 1280-1285.
55. (1994) Methods in neuroscience. Providing therapeutic access to the brain: New approaches, Academic Press, New York, NY
56. Florence, AT, Hillery, AM, Hussain, N. and Jani, PU (1995) Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate. J Control Release, 36, pp. 39-46.
57. Foster, N., Clark, M., Jepson, M. and Hirst, B. (1998) Ulex europaeus 1 lectin targets mcirospheres to mouse Peyer's patch M-cells in vivo. Vaccine, 16, pp. 536-541.
58. Freitas, RA (1999) Nanomedicine. Basic capabilities, Landes BioScience, Georgetown, TX
59. Fresta, M., Puglisi, G., Giacomo, C Di and Russo, A. (1994) Liposomes as in-vivo carriers for citicoline: Effects on rat cerebral post-ischaemic reperfusion. J Pharm Pharmacol, 46, pp. 974-981.
60. Gabizon, A., Shmeeda, H. and Barenholz, Y. (2003) Pharmacokinetics of pegylated liposomal doxorubicin: Review of animal and human studies. Clin Pharmacokin, 42, pp. 419-436.
61. Galindo-Rodriguez, SA, Allemann, E., Fessi, H. and Doelker, E. (2005) Polymeric nanoparticles for oral delivery of drugs and vaccines: A critical evaluation of in vivo studies. Crit Rev Ther Drug Carrier Syst, 22, pp. 419-464.
62. Gao, X., Cui, Y., Levenson, RM, Chung, L. and Nie, S. (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol, 22, pp. 969-976.
63. Gelperina, S., Smirnova, Z. and Skidan, JK (2000) Proceedings of 3rd World Meeting APV/APGI: Berlin.pp. 441-442.
64. Gilles, ER and Frechet, JM (2005) Dendrimers and dendritic polymers in drug delivery. Drug Discov Today, 10, pp. 35-43.
65. Goldstein, A., Amory, J., Martin, S., Vernon, C., Matsumoto, A. and Yager, P. (2001) Testosterone delivery using glutamide-based complex high axial ratio microstructures. Bioorg Med Chem, 9, pp. 2819-2825.
66. Goren, D., Horwitz, AT, Tzemach, D., Tarshish, M., Zalipsky, S. and Gabizon, A. (2000) Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res, 6, pp. 1949-1957.
67. Gourley, PL (2005) Brief overview of BioMicroNano technologies. Biotechnol Prog, 21, pp. 2-10.
68. Grubisha, DS, Lipert, RJ, Park, HY, Driskell, J. and Porter, MD (2003) Femtomolar detection of prostate-specific antigen: An immunoassay based on surface-enhanced Raman scattering and immunogold labels. Anal Chem, 75, pp. 5936-5943.
69. Gulyaev, AE, Gelperina, SE, Skidan, IN, Antropov, AS, Kivman, GY and Kreuter, J. (1999) Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. J Pharm Res, 16, pp. 1564-1569.
70. Hamaguchi, T., Matusmura, Y., Suzuki, M., Shimizu, K., Goda, R., Nakamura, I., Nakatomi, I., Yokoyama, M., Kataoka, K. and Kakizoe, T. (2005) NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumor activity and reduce the neurotoxicity of paclitaxel. Br J Cancer, 92, pp. 1240-1246.
71. Harisinghani, MG, Barentsz, J., Hahn, PF, Deserno, WM, Tabatabaei, S., van de Kaa, C Hulsbergen, de la Rosette, J. and Weissleder, R. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med, 348, pp. 2491-2499.
72. Hau, P., Fabel, K., Baumgart, U., Rummele, P., Grauer, O., Bock, A., Dietmaier, C., Dietmaier, W., Dietrich, J., Dudel, C., Hubner, F., Jauch, T., Drechsel, E., Kleiter, I., Wismeth, C., Zellner, A., Brawanski, A., Steinbrecher, A., Marienhagen, J. and Bogdahn, U. (2004) Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer, 100, pp. 1199-1207.
73. Hillyer, J. and Albrecht, R. (2001) Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci, 90, pp. 1927-1936.
74. Hirsch, LR, Jackson, JB, Lee, A., Halas, NJ and West, JL (2003) A whole blood immunoassay using gold nanoshells. Anal Chem, 75, pp. 2377-2381.
75. Hood, JD, Bednarski, M., Frausto, R., Guccione, S., Reisfeld, RA, Xiang, R. and Cheresh, DA (2002) Tumor regression by targeted gene delivery to the neovasculature. Science, 296, pp. 2404-2407.
76. Hoshi, S., Uchino, A., Kusanagi, K., Ihara, T. and Ueda, S. (1999) Uptake of orally administered polystyrene latex and poly(,-lactic/ glycolic acid) microspheres into intestinal lymphoid tissues in chickens. Vet Immunol Immunopathol, 70, pp. 33-42.
77. Hussain, N., Jaitley, V. and Florence, A. (2001) Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev, 50, pp. 107-142.
78. Huwyler, J., Cerletti, A., Fricker, G., Eberle, AN and Drewe, J. (2002) By-passing of P-glycoprotein using immunoliposomes. J Drug Target, 10, pp. 73-79.
79. Imaizumi, S., Woolworth, V., Fishman, RA and Chan, PH (1990) Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke, 2, pp. 1312-1317.
80. Ito, T., Sun, L. and Crooks, RM (2003) Simultaneous determination of the size and surface charge of individual nanoparticles using a carbon nanotube-based Coulter counter. Anal Chem, 75, pp. 2399-2406.
81. Jacob, J., Santos, C., Carino, G., Chickering, D. and Mathiowitz, E. (1995) An in vitro bioassay for quantification of bioadhesion of polymer microspheres to mucosal epithelium. Proc Int Symp Control Release Bioact Mat, 22, pp. 312-313.
82. Jani, P., Halbert, GW, Langridge, J. and Florence, AT (1990) Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J Pharm Pharmacol, 42, pp. 821-826.
83. Jani, P., Halbert, GW, Langridge, J. and Florence, AT (1989) The uptake and translocation of latex nanospheres after oral administration to rats. J Pharm Pharmacol, 41, pp. 809-812.
84. Jani, PU, Florence, AT and McCarthy, DE (1992) Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int J Pharm, 33, pp. 245-252.
85. Jani, P., McCarthy, DE and Florence, AT (1994) Titanium dioxide (Rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int J Pharm, 1994, pp. 157-169.
86. Jani, P., Nomura, T., Yamashita, F., Takakura, Y., Florence, AT and Hashida, H. (1996) Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescence after oral and parenteral administration to male Wistar rats. J Drug Target, 4, pp. 87-93.
87. Jiang, C., Koyabu, N., Yonemitsu, Y., Shimazoe, T., Watanabe, S., Naito, M., Tsuruo, T., Ohtani, H. and Sawada, Y. (2003) In vivo delivery of glial cell-derived neurotrophic factor across the blood-brain barrier by gene transfer into brain capillary endothelial cells. Hum Gene Ther, 14, pp. 1181-1191.
88. Jain, S., Mishra, V., Singh, P., Dubey, PK, Saraf, DK and Vyas, SP (2003) RGD-anchored magnetic liposomes for monocytes/ neutrophils-mediated brain targeting. Int J Pharm, 261, pp. 43-55.
89. Jin, R., Cao, Y., Mirkin, CA, Kelley, KL, Schatz, GC and Zheng, JG (2001) Photoinduced conversion of silver nanospheres to nanoprisms. Science, 294, pp. 1901-1903.
90. 2 activation and their use in liposome-based drug delivery. FEBS Lett, 531, pp. 23-27.
91. Kakinuma, K., Tanaka, R., Takahashi, H., Sekihara, Y., Watanabe, M. and Kuroki, M. (1996) Drug delivery to the brain using thermosensitive liposome and local hyperthermia. Int J Hypertherm, 12, pp. 157-165.
92. Kim, S., Bell, K., Mousa, SA and Varner, JA (2000) A regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin. Am J Pathol, 156, pp. 1345-1362.
93. Kim, S., Lim, YT, Soltesz, EG, De Grand, AM, Lee, J., Nakayama, A., Parker, JA, Mihaljevic, T., Laurence, RG and Dor, DM (2004) Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol, 22, pp. 93-97.
94. Kitchens, KM, Kolhatkar, RB, Swaan, PW, Eddington, ND and Ghandehari, H. (2006) Transport of poly(aminoamine) dendrimers across Caco-2 monolayers: Influence of size, charge, and fluorescent labeling. Pharm Res, 23, pp. 2818-2826.
95. Koushik, K., Dhanda, DS, Cheruvu, NP and Kompella, UB (2004) Pulmonary delivery of deslorelin: Large-porous PLGA particles and HpbetaCD complexes. Pharm Res, 21, pp. 1119-1126.
96. Koziara, JM, Lockman, PR, Allen, DD and Mumper, RJ (2004) Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release, 99, pp. 259-269.
97. Kreuter, J., Alyautdin, RN, Kharkevich, DA and Ivanov, AA (1995) Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res, 674, pp. 171-174.
98. Kreuter, J., Petrov, VE, Kharkevich, DA and Alyautdin, RN (1997) Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. J Control Release, 49, pp. 81-87.
99. Kreuter, J. (2004) Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol, 4, pp. 484-488.
100. Kukowska-Latallo, J., Raczka, E., Quintana, A., Chen, C., Rymaszewski, M. and Baker, JR (2000) Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. Hum Gene Ther, 11, pp. 1385-1395.
101. Labhasetwar, V. (2005) Nanotechnology for drug and gene therapy: The importance of understanding molecular mechanisms of delivery. Curr Opin Biotechnol, pp. 674-680.
102. Lanza, GM, Wallace, KD, Scott, MJ, Cacheris, WP, Abendschein, DR, Christy, DH, Sharkey, AM, Miller, JG, Gaffney, PJ and Wickline, SA (1996) A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation, 94, pp. 3334-3340.
103. Lanza, GM, Lorenz, CH, Fischer, SE, Scott, MJ, Cacheris, WP, Kaufman, RJ, Gaffney, PJ and Wickline, SA (1998) Enhanced detection of thrombi with a novel fibrin targeted magnetic resonance imaging agent. Acad Radiol, 5, pp. S173-S176.
104. Lanza, GM, Trousil, RL, Wallace, KD, Rose, JH, Hall, CS, Scott, MJ, Miller, JG, Eisenberg, PR, Gaffney, PJ and Wickline, SA (1998) In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J Acoust Soc Am, 104, pp. 3665-3672.
105. Lanza, GM, Abendschein, DR, Hall, CS, Marsh, JN, Scott, MJ, Scherrer, DE and Wickline, SA (2000) Molecular imaging of stretch induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest Radiol, 35, pp. 227-234.
106. Lanza, GM, Winter, PM, Abendschein, DR, Karukstis, KK, Scott, MJ, Chinen, LK, Fuhrhop, RW, Scherrer, DE and Wickline, SA (2002) Targeted antiproliferative drug delivery to vascular smooth muscle cells with magnetic resonance imaging nanoparticle contrast agent: Implications for rational therapy of restenosis. Circulation, 106, pp. 2842-2847.
107. Lanza, GM, Winter, PM, Neubauer, AM, Caruthers, SD, Hockette, FD and Wickline, SA (2005) (1)H/(19)F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. Curr Top Dev Biol, pp. 57-76.
108. Ng, HT, Cassell, A., Fan, W., Chen, H., Koehne, J., Han, J. and Meyyappan, M. (2003) Carbon nanotube nanoelectrode array for ultrasensitive DNA detection. Nano Lett, 3, pp. 597-602.
109. Limpanussorn, J., Simon, L. and Dayan, AD (1998) Transepithelial transport of large particles in rat: A new model for the quantitative study of particle uptake. J Pharm Pharmacol, 50, pp. 753-760.
110. Liu, L., Zern, M., Lizarzaburu, M. and Nantz, MH (2003) Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver. Gene Ther, 10, pp. 180-187.
111. Liu, L., Khang, G., Rhee, J. and Lee, H. (2000) Monolithic osmotic tablet system for nifedipine delivery. J Control release, 67, pp. 309-322.
112. Loeb, C., Benassi, E., Besio, G., Maffini, M. and Tanganelli, P. (1982) Liposome-entrapped GABA modifies behavioral and electrographic changes of penicillin-induced epileptic activity. Neurology, 32, pp. 1234-1238.
113. Loscertales, I., Barrero, A., Guerrero, I., Cortijo, R., Marquez, M. and Ganan-Calvo, AM (2002) Micro/nano encapsulation via electrified coaxial liquid jets. Science, 295, pp. 1695-1698.
114. Low, PS and Antony, AC (2004) Folate receptor targeted drugs for cancer and inflammatory diseases. Adv Drug Deliv Rev, 56, pp. 1055-1058.
115. Low, PS (2002) Folate-mdeiated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev, 54, pp. 675-693.
116. Lubben, IVD, Konings, F. and Borchard, G. (2001) In vivo uptake of chitosan microparticles by murine Peyer's patches: Visualization studies using confocal laser scanning microscopy and immunohistochemistry. J Drug Target, 9, pp. 39-47.
117. Lutsiak, M., Robinson, D., Coester, C., Kwon, GS and Samuel, J. (2002) Analysis of poly(,-lactic- co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Pharm Res, 19, pp. 1480-1487.
118. Maksimento, A., Mandroguine, V. and Gottikh, M. (2003) Optimisation of dendrimer-mediated gene transfer by anionic oligomers. J Gene Med, 5, pp. 61-71.
119. Martin, C. and Kohli, P. (2002) The emerging field of nanotube biotechnology. Nat Rev Drug Discov, 2, pp. 29-35.
120. Mathiowitz, E., Saltzman, WM, Domb, A., Dor, P. and Langer, R. (1988) Polyanhydride microspheres as drug carriers II. Microencapsulation by solvent removal. J Appl Polym Sci, 35, pp. 755-774.
121. Mathiowitz, E., Jacob, JS, Jong, YS, Carino, G., Chickering, DE, Chaturverdi, P., Santos, CA, Vijayaraghavan, K., Montgomery, S., Bassett, M. and Morrell, C. (1997) Biologically erodible microspheres as potential oral drug delivery systems. Nature, 386, pp. 410-414.
122. Mathiowitz, E., Chickering, D., Jacob, M. and Santos, C. (1999) Bioadhesive drug delivery systems. Encyclopedia of controlled drug delivery, Wiley and Sons, New York, NY
123. McIntyre, JO, Fingleton, B., Wells, KS, Piston, DW, Lynch, CC, Gautam, S. and Matrisian, LM (2004) Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. Biochem J, 377, pp. 617-628.
124. McKinnie, J. (2006) Nanobiotechnology offers a promising solution overcoming common drug delivery failures. Drug Deliv Technol, 5, pp. 11-15.
125. McLean, S., Prosser, E., Meehan, E., O'Malley, D., Clarke, D., Ramtoola, Z. and Brayden, D. (1997) Binding and uptake of biodegradable poly--lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci, 6, pp. 153-163.
126. McMinn, LH, Hodges, GM and Carr, KE (1996) Gastrointestinal uptake and translocation of microparticles in the streptozotocin-diabetic rat. J Anat, 189, pp. 533-539.
127. McShane, M. (2002) Potential for glucose monitoring with nanoengineered fluorescent biosensors. Diabetes Technol Ther, 4, pp. 533-538.
128. Miyata, N. and Yamakoshi, T. (1997) Fullerenes: Recent advances in the chemistry and physics of fullerenes and related materials, pp. 345-357. Electrochemical Society, Pennington, NJ
129. Moghimi, SM and Bonnemain, B. (1999) Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: Applications in lymphoscintigraphy and indirect lymphography. Adv Drug Deliv Rev, 37, pp. 295-312.
130. Moghimi, SM and Hunter, AC (2001) Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. Pharm Res, 18, pp. 1-8.
131. Moghimi, SM, Hunter, AC and Murray, JC (2001) Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev, 53, pp. 283-318.
132. Moghimi, SM (2003) Modulation of lymphatic distribution of subcutaneously injected poloxamer 407-coated nanospheres: The effect of the ethylene oxide chain configuration. FEBS Lett, 540, pp. 241-244.
133. Moghimi, SM, Hunter, AC and Murray, JC (2003) Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev, 53, pp. 283-318.
134. Moghimi, SM and Szebeni, J. (2003) Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res, 42, pp. 463-478.
135. Moghimi, M., Hunter, AC and Murray, JC (2005) Nanomedicine: Current status and future prospects. FASEB, 19, pp. 311-330.
136. Mori, N., Kurokouchi, A., Osonoe, K., Saitoh, H., Ariga, K., Suzuki, K. and Iwata, Y. (1995) Liposome-entrapped phenytoin locally suppresses amygdaloid epileptogenic focus created by db-cAMP/EDTA in rats. Brain Res, 703, pp. 184-190.
137. Murray, JC and Moghimi, SM (2003) Endothelial cells as therapeutic targets in cancer: New biology and novel delivery systems. Crit Rev Ther Drug Carrier Syst, 20, pp. 139-152.
138. Muzykantov, VR, Christofidou-Solomidou, M., Balyasnikova, IV, Harshaw, D., Schultz, L., Fisher, AB and Albelda, SM (1999) Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule-1): A strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci USA, 96, pp. 2379-2384.
139. Najlah, M., Freeman, S., Attwood, D. and D'Emanuele, A. (2006) Synthesis, characterization, and stability of dendrimer prodrugs. Int J Pharm, 308, p. 1750182.
140. Najlah, M., Freeman, S., Attwood, D. and D'Emanuele, A. (2006) In vitro evaluation of dendrimer prodrugs for oral delivery. Int J Pharm
141. Nam, JM, Thaxton, CS and Mirkin, CA (2003) Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science, 301, pp. 1884-1886.
142. Nam, JM, Stoeva, SI and Mirkin, CA (2004) Biol-bar-code-based DNA detection with PCR like sensitivity. J Am Chem Soc, 126, pp. 5932-5933.
143. Nel, A., Xia, T. and Madler, L. (2006) Tox potential of materials at the nanolevel. Science, 311, pp. 622-627.
144. Durr, E., Krasinka, KM, Carver, LA, Testa, JE and Schnitzer, JE (2004) Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (London), 429, pp. 629-635.
145. Onodera, H., Takada, G., Tada, K. and Desnick, RJ (1983) Microautoradiographic study on the tissue localization of liposome-entrapped or unentrapped 3H-labeled beta-galactosidase injected into rats. Tohoku J Exp Med, 140, pp. 1-13.
146. Panyam, J. and Labhasetwar, V. (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 12, pp. 329-347.
147. Pappo, J. and Ermak, TH (1989) Uptake and translocation of fluorescent latex particles by rabbit peyer's patch follicle epithelium: A quantitative model for M cell uptake. Clin Exp Immunol, 76, pp. 144-148.
148. Pardridge, WM (2005) The blood-brain barrier: Bottleneck in brain drug development. NeuroRx., 2, pp. 3-14.
149. Pasqualini, R., Arap, W. and McDonald, DM (2002) Probing the structural and molecular diversity of tumour vasculature. Trends Mol Med, 8, pp. 563-571.
150. Pastorino, F., Brignole, C., Marimpietri, D., Cilli, M., Gambini, C., Ribatti, D., Longhi, R., Allen, TM, Corti, A. and Ponzoni, M. (2003) Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. Cancer Res, 63, pp. 7400-7409.
151. Perez, C., Sanchez, A., Putnam, D., Ting, D., Langer, R. and Alonso, MJ (2001) Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Control Release, 75, pp. 211-224.
152. Ponchel, G. and Duchêne, D. (1991) Development of a bioadhesive tablet. High performance biomaterials, pp. 231-242. Technomic Publishing Company, Inc., Lancaster, PA
153. Postmes, TJ, Hukkelhoven, M., Bogaard, AE van den, Halders, SG and Coenegracht, J. (1980) Passage through the blood-brain barrier of thyrotropin-releasing hormone encapsulated in liposomes. J Pharm Pharmacol, 32, pp. 722-724.
154. Ramge, P., Kreuter, J. and Lemmer, B. (1999) Circadian phase-dependent antinociceptive reaction in mice determined by the hot-plate test and the tail-flick test after intravenous injection of dalargin-loaded nanoparticles. Chronobiol Int, 16, pp. 767-777.
155. Ran, S., Gao, B., Duffy, S., Watkins, L., Rote, N. and Thorpe, PE (1998) Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumour vasculature. Cancer Res, 58, pp. 4646-4653.
156. Remaut, K., Lucas, B., Braeckmans, K., Sanders, NN, Demeester, J. and DeSmedt, SC (2005) Protection of oligonucleotides against nucleases by pegylated and non-pegylated liposomes as studied by fluorescence correlation spectroscopy. J Control Release, 110, pp. 212-226.
157. Roney, C., Kulkarni, P. and Arora, V. (2005) Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. J Control Release, 108, pp. 193-214.
158. Rosi, NL and Mirkin, CA (2005) Nanostructures in biodiagnostics. Chem Rev, 105, pp. 1547-1562.
159. Ruoslahti, E. (2002) Drug targeting to specific vascular sites. Drug Discov Today, 7, pp. 1138-1143.
160. Sapra, P. and Allen, TM (2002) Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. Cancer Res, 62, pp. 7190-7194.
161. Schackert, G., Fan, D., Nayar, R. and Fidler, I. (1989) Arrest and retention of multilamellar liposomes in the brain of normal mice or mice bearing experimental brain metastases. Sel Cancer Ther, 5, pp. 73-79.
162. Scherpereel, A., Wiewrodt, R., Christofidou-Solomidou, M., Gervais, R., Murciano, JC, Albelda, SM and Muzykantov, VR (2001) Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting. FASEB J, 15, pp. 416-426.
163. Schinazi, RF, Sijbesma, R., Srdanov, G., Hill, CL and Wudl, F. (1993) Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene. Antimicrob Agents Chemother, 37, pp. 1707-1710.
164. Schinkel, A. (1999) P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev, 36, pp. 179-194.
165. Schroder, U. and Sabel, BA (1996) Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections. Brain Res, 710, pp. 121-124.
166. Schroeder, U., Sommerfeld, P., Ulrich, S. and Sabel, BA (1998) Nanoparticle technology for delivery of drugs across the blood-brain barrier. J Pharm Sci, 87, pp. 1305-1307.
167. Shi, N., Zhang, Y., Zhu, C., Boado, RJ and Pardridge, WM (2001) Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci USA, 98, pp. 12754-12759.
168. Silva, GA (2006) Neuroscience nanotechnology: Progress, opportunities and challenges. Nat Rev Neurosci, 7, pp. 65-74.
169. Singh, R., Pantarotto, D., Lacerdo, L., Pastorin, G., Klumpp, C., Prato, M., Bianco, A. and Kostarelos, K. (2006) Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA, 103, pp. 3357-3362.
170. Sinha, J., Das, N. and Basu, MK (2001) Liposomal antioxidants in combating ischemia-reperfusion injury in rat brain. Biomed Pharmacother, 55, pp. 264-271.
171. Croix, B St, Rago, C., Velculescu, V., Traverso, G., Romans, KE, Montgomery, E., Lal, A., Riggins, GJ, Lengauer, C., Vogelstein, B. and Kinzler, KW (2000) Genes expressed in human tumor endothelium. Science, 289, pp. 1197-1202.
172. Sudimack, J. and Lee, RJ (2000) Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev, 41, pp. 147-162.
173. Sumner, JP, Aylott, JW, Monson, E. and Kopelman, R. (2002) A fluorescent
174. Tabata, Y., Murakami, Y. and Ikada, Y. (1997) Photodynamic effect of polyethylene glycolmodified fullerene on tumor. Jpn J Cancer Res, 88, pp. 1108-1116.
175. Tabata, Y., Murakami, Y. and Ikada, Y. (1997) Antitumor effect of poly(ethylene glycol)-modified fullerene. Fullerene Sci Technol, 5, pp. 989-1007.
176. Taton, TA, Mirkin, CA and Letsonger, RL (2000) Scanometric DNA array detection with nanoparticle probes. Science, 289, pp. 1757-1760.
177. Thanos, C., Liu, Z., Goddard, M., Reineke, J., Bailey, N., Cross, M., Burrill, R. and Mathiowitz, E. (2003) Enhancing the oral bioavailability of the poorly soluble drug dicumarol with a bioadhesive polymer. J Pharm Sci, 92, pp. 1677-1689.
178. Thanos, C., Liu, Z., Reineke, J., Edwards, E. and Mathiowitz, E. (2003) Improving relative bioavailability of dicumarol by reducing particle size and adding the adhesive poly(fumaric-co-sebacic) anhydride. Pharm Res, 20, pp. 1093-1100.
179. Tiwri, SB and Amuji, MM (2006) A review of nanocarrier-based CNS delivery systems. Curr Drug Deliv, 3, pp. 219-232.
180. Tokes, ZA, Peteri, AK St and Todd, JA (1980) Availability of liposome content to the nervous system. Liposomes and the blood-brain barrier. Brain Res, 188, pp. 282-286.
181. Torche, A., Jouan, H., Corre, PL, Chevanne, F. and Verge, R Le (2000) Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment. Int J Pharm, 201, pp. 15-27.
182. Torchillin, VP, Lukyanov, AN and Gao, ZG (2003) Papahadjopoulos-Sternberg B. Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA, 100, pp. 6039-6044.
183. Tsao, N., Kanakaama, PP, Luh, TY, Chou, CK and Lei, HY (1999) Inhibition of Escherichia coli-induced meningitis by carboxyfullerence. Antimicrob Agents Chemother, 43, pp. 2273-2277.
184. Tsao, N., Luh, TY, Chou, CK, Wu, JJ, Lin, YS and Lei, HY (2001) Inhibition of group A streptococcus infection by carboxyfullerene. Antimicrob Agents Chemother, 45, pp. 1788-1793.
185. Turunen, MP, Puhakka, HL, Koponen, JK, Hiltunen, MO, Rutanen, J., Leppanen, O., Turunen, AM, Narvanen, A., Newby, AC and Baker, AH (2002) Peptide re-targeted adenovirus encoding a tissue inhibitor of metalloproteinase-1 decreases restenosis after intravascular gene transfer. Mol Ther, 6, pp. 306-312.
186. Tziveleka, LA, Kontoyianni, C., Sideratou, Z., Tsiourvas, D. and Paleos, CM (2006) Novel hyperbranched polyether polyols as prospective drug delivery systems. Macromol Biosci, 6, pp. 161-169.
187. Varde, NK and Pack, DW (2004) Microspheres for controlled release drug delivery. Expert Opin Biol Ther, 4, pp. 35-51.
188. Vasir, JK and Labhasetwar, V. (2005) Targeted drug delivery in cancer therapy. Technol Cancer Res Treat, 25, pp. 363-374.
189. VisionGain (2003) Drug delivery 2003 new technologies in the global market
190. Wang, J. and Musameh, M. (2003) Carbon nanotube/teflon composite electrochemical sensors and biosensors. Anal Chem, 75, pp. 2075-2079.
191. Weissleder, R., Kelly, K., Sun, EY, Shtatland, T. and Josephson, L. (2005) Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol, 11, pp. 1418-1423.
192. Wickline, SA and Lanza, GM (2003) Nanotechnology for molecular imaging and targeted therapy. Circulation, 107, pp. 1092-1095.
193. Win, K. and Feng, S. (2005) Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26, pp. 2713-2722.
194. Winter, PM, Caruthers, SD, Kassner, A., Harris, TD, Chinen, LK, Allen, JS, Lacy, EK, Zhang, HY, Robertson, JD and Wickline, SA (2003) Molecular imaging of angiogenesis in nascent vx-2 rabbit tumours using a novel alpha(v)beta(3)-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res, 63, pp. 5838-5843.
195. Woolley, AT, Guillemette, C., LiCheung, C., Housman, DE and Lieber, CM (2000) Direct haplotyping of kilobase-size DNA using carbon nanotube probes. Nat Biotechnol, 18, pp. 760-763.
196. Wunderbaldinger, P., Josephson, L. and Weissleder, R. (2002) Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem, 13, pp. 264-268.
197. Yang, J., Mayer, M., Kriebel, JK, Garstecki, P. and Whitesides, GM (2004) Self-assembled aggregates of IgGs as templates for the growth of clusters of gold nanoparticles. Angew Chem Int Ed Engl, 43, pp. 1555-1558.
198. Yong, CS, Lee, MK, Park, YJ, Kong, KH, Xuan, JJ, Kim, JH, Kim, JA, Lyoo, WS, Han, SS, Rhee, JD, Kim, JO, Yang, CH, Kim, CK and Choi, HG (2005) Enhanced oral bioavailability of ibuprofen in rats by poloxamer gel using poloxamer 188 and menthol. Drug Dev Ind Pharm, 31, pp. 615-622.
199. Song, S-K, Chen, J., Scott, MJ, Fuhrhop, RJ, Hall, CS, Gaffney, PJ, Wickline, SA and Lanza, GM (2000) High resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med, 44, pp. 867-872.
200. Zara, GP, Bargoni, A., Cavalli, R., Fundaro, A., Vighetto, D. and Gasco, MR (2002) Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats. J Pharm Sci, 91, pp. 1324-1333.
201. Zara, GP, Cavalli, R., Bargoni, A., Fundaro, A., Vighetto, D. and Gasco, MR (2004) Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: Pharmacokinetics and distribution of doxorubicin in brain and other tissues. J Drug Target, 10, pp. 327-335.
202. Zhang, Y., Schlachetzkif, F. and Pardridge, W. (2003) Global non-viral gene transfer to the primate brain following intravenous administration. Mol Ther, 7, pp. 11-18.
203. Zitzmann, S., Ehemann, V. and Schwab, M. (2002) Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res, 62, pp. 5139-5143.